App-based Stress Management With the mHealth Application "Harmony"

March 19, 2026 updated by: Christina Hunger-Schoppe, University of Witten/Herdecke

App-based Stress Management: A Pragmatic Randomized Controlled Trial on the Efficacy of the mHealth Application "Harmony"

The purpose of this study is to investigate the efficacy of app-based stress prevention via the harmony application in a prospective, interventive, monocentric, explanatory pilot randomized controlled trial (RCT), with participants' subjective stress experience as the primary endpoint.

Research question: Does usage of the app harmony have a positive impact on the subjective experience of stress of its users? Do usage frequency, intensity or width of content engagement influence the efficacy of the intervention?

Hypothesis: We expect improvement of participants' subjective stress experience, stress-related symptoms, subjective well-being, resilient coping, self-efficacy, life satisfaction and goal-attainment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

251

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Rhine-Westphalia
      • Witten, North Rhine-Westphalia, Germany, 58455
        • Witten/Herdecke University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Increased stress level (PSS-10 >= 19; corresponds to one standard deviation (SD 6.42)) above the mean (PSS-10 = 12.57) in a representative sample of the German population (Klein et al., 2016)
  • Fulfillment of technical minimum requirements (internet and smartphone access with suitable operating systems)
  • German language skills at a native level or the ability to use the language at at least B level
  • Written informed consent to participate in the study after being informed about the study

Exclusion Criteria:

  • Inclusion criteria not met.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: App-usage across a 12 week time period
Use of the harmony application, with 6- and 12-week follow-up. Measurements will be taken at baseline as well as at 6- and 12-week follow-up.
Use of the app-based digital self-help intervention harmony over a 12-week-period. The app was designed for stress management and the preventive promotion of mental health. Harmony provides users with access to a wide range of psychological self-help content, including video episodes, audio sessions, texts, and downloadable materials. Utilizing artificial intelligence, Harmony offers personalized content suggestions tailored to the user's individual situation and preferences, ensuring the content remains relevant and updated. Content is delivered through a combination of psychoeducation, guided exercises, relaxation techniques, meditations, practical tasks, self-reflection activities, and everyday application tasks.
No Intervention: Waitlist-control group
Use of the harmony application after a 12-week waiting period. Measurements will be taken at baseline as well as at 6- and 12-week follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline stress at 6 weeks and 12 months
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Perceived Stress Scale (PSS-10, Cohen et al., 1983): Self-report measure to assess psychological stress levels; Likert scale: 1 = never, 5 = very often.
Baseline, 6-week follow-up, 12-week follow-up
Change from baseline stress symptoms at 6 weeks and 12 months
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Stress and Coping Inventory (SCI; Satow, 2024): Self-report measure to assess psychological and physical stress symptoms; Likert scale: 1 = completely true (negative), 4 = not true at all (positive)
Baseline, 6-week follow-up, 12-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective well-being
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
WHO-5 Well-Being Index (WHO-5; WHO, 1998): Self-report measure to assess subjective well-being. Likert scale from 0 = at no time to 5 = all of the time.
Baseline, 6-week follow-up, 12-week follow-up
Resilient coping
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Brief resilient coping scale (BRCS; Kocalevent et al., 2014): Self-report measure to assess an individual's ability to cope with stress in a resilient manner. Likert scale from 1 = describes me not at all to 5 = describes me very well.
Baseline, 6-week follow-up, 12-week follow-up
Self-efficacy
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
General Self-Efficacy Scale (GSE-SI; Di et al., 2023): One-item self-report measure to assess an individual's belief in their ability to perform tasks and handle situations effectively across a variety of contexts.
Baseline, 6-week follow-up, 12-week follow-up
Life satisfaction
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Life Satisfaction Scale (L-1; Beierlein et al., 2015): One-item self-report measure to assess a person's subjective evaluation of their quality of life. Likert scale from 1 = not satisfied at all to 11 = completely satisfied.
Baseline, 6-week follow-up, 12-week follow-up
Goal Attainment
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Goal Attainment Scaling (GAS; Grosse Holtforth & Grawe, 2002): Self-report measure to assess participants' previously set goals and their achievement; Scale from 0% to 100% in steps of 10%
Baseline, 6-week follow-up, 12-week follow-up
Experience in Social Systems (EXIS; Hunger et al., 2017)
Time Frame: Baseline, 6-week follow-up, 12-week follow-up
Self-report measure to assess systemic functioning in private and organizational social systems; Likert scale: 1 = not at all (negative), 6 = fully (positive)
Baseline, 6-week follow-up, 12-week follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of application use
Time Frame: 6-week follow-up, 12-week follow-up (experiment group only)
Participants' self report on absolut app usage over the past 6 weeks in days.
6-week follow-up, 12-week follow-up (experiment group only)
Duration of application use
Time Frame: 6-week follow-up, 12-week follow-up (experiment group only)
Participants' self report on average app usage in minutes per session.
6-week follow-up, 12-week follow-up (experiment group only)
Extent of application use
Time Frame: 6-week follow-up, 12-week follow-up (experiment group only)
Participants' self report on the extent of usage of different features within the app over the past six weeks. Respondents are asked to indicate which of the following functions they have used: Video, meditation, resilience course, texts, downloadable materials, and mental health checkup. Additionally, respondents specify the frequency of usage for each function.
6-week follow-up, 12-week follow-up (experiment group only)
User experience
Time Frame: 6-week follow-up, 12-week follow-up (experiment group only)
Participants' self-report on overall impressions of the app. Likert scale from 1 = don't agree at all to 5 = completely agree
6-week follow-up, 12-week follow-up (experiment group only)
User satisfaction
Time Frame: 6-week follow-up, 12-week follow-up (experiment group only)
Participants' self report on overall satisfaction with their experience using the app. Likert scale from 1 = very bad to 5 = very good
6-week follow-up, 12-week follow-up (experiment group only)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Christina Hunger-Schoppe, Prof. Dr., University of Witten/Herdecke

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

March 3, 2025

Study Completion (Actual)

March 3, 2025

Study Registration Dates

First Submitted

September 9, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

December 20, 2024

Study Record Updates

Last Update Posted (Actual)

March 24, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on harmony

Subscribe